• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心源性休克患者的三尖瓣反流与慢性肾脏病:文献综述及单中心真实世界经验

Tricuspid regurgitation and chronic kidney disease in patients with cardiogenic shock: Review of the literature and real-world experience from a single center.

作者信息

Oren Daniel, Ramchandani Sunil, Lorenzana Adrian, Nair Ranjit, Szinte Julia, Maalizadeh Kian, Ftiha Farage, Moeller Cathrine M, Fernandez-Valledor Andrea, Cohen Roi Bar, Zepeda Ignacio, Alishetti Shudhanshu, Mihatov Nino, Ramasubbu Kumudha, Minkin Ruth, Saleh Anthony, Parikh Manish A, Fenton Franklyn, Peterson Stephen J

机构信息

Department of Medicine, New York Presbyterian, Brooklyn Methodist Hospital, Weill Cornell Medicine, NY, USA.

Department of Medicine, Icahn School of Medicine at Mount Sinai West and St. Luke's Hospitals, NY, USA.

出版信息

Int J Cardiol Heart Vasc. 2025 Jun 7;59:101716. doi: 10.1016/j.ijcha.2025.101716. eCollection 2025 Aug.

DOI:10.1016/j.ijcha.2025.101716
PMID:40535596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12175724/
Abstract

INTRODUCTION

Chronic kidney disease (CKD) frequently complicates Congestive Heart Failure (CHF) and can worsen outcomes in cardiogenic shock. Tricuspid Regurgitation (TR), by elevating central venous pressure, may exacerbate renal impairment. Limited data exist regarding CKD's influence in TR interventions. This study assesses the impact of CKD on survival and explores RV dysfunction as a potential mediator in patients with TR in cardiogenic shock.

METHODS

We retrospectively analyzed patients admitted with HF-related or myocardial infarction-induced cardiogenic shock (2021-2025). Patients were stratified by TR severity (none/trivial, mild, moderate, severe) and CKD stage. Echocardiographic, laboratory, and hemodynamic data were collected. RV dysfunction was assessed using echocardiography and right heart catheterization. Survival outcomes, including HF readmissions and mortality, were evaluated using Kaplan-Meier analysis and Cox regression, considering predictors significant at p < 0.10.

RESULTS

Among 177 patients (median age 70 years, EF 35 %, 46 % Black), 55 % had CKD. TR severity distribution was: none/trivial 42 %, mild 16 %, moderate 22 %, and severe 20 %. Severe TR significantly increased in-hospital mortality (40 %) compared to non-severe TR (24 %) and correlated with worsening CKD stages. HF readmissions within 12 months occurred in 10 % of patients. Older age and RV dysfunction emerged as the strongest mortality predictors. Severe TR independently increased mortality and readmission risk.

CONCLUSION

Severe TR significantly worsens survival in cardiogenic shock patients, especially those with advanced CKD, mediated by RV dysfunction. CKD severity assessment may enhance patient stratification for valve interventions. Randomized studies are required to further validate these findings.

摘要

引言

慢性肾脏病(CKD)常使充血性心力衰竭(CHF)复杂化,并可能使心源性休克的预后恶化。三尖瓣反流(TR)通过升高中心静脉压,可能会加重肾功能损害。关于CKD对TR干预影响的数据有限。本研究评估CKD对生存率的影响,并探讨右心室功能障碍作为心源性休克TR患者潜在中介因素的作用。

方法

我们回顾性分析了因心力衰竭相关或心肌梗死诱发的心源性休克入院的患者(2021 - 2025年)。患者按TR严重程度(无/轻微、轻度、中度、重度)和CKD分期进行分层。收集了超声心动图、实验室和血流动力学数据。使用超声心动图和右心导管检查评估右心室功能障碍。使用Kaplan - Meier分析和Cox回归评估生存结局,包括心力衰竭再入院率和死亡率,考虑p < 0.10时具有显著意义的预测因素。

结果

在177例患者(中位年龄70岁,射血分数35%,46%为黑人)中,55%患有CKD。TR严重程度分布为:无/轻微42%,轻度16%,中度22%,重度20%。与非重度TR(24%)相比,重度TR显著增加了住院死亡率(40%),并与CKD分期恶化相关。10%的患者在12个月内发生心力衰竭再入院。年龄较大和右心室功能障碍是最强的死亡预测因素。重度TR独立增加死亡率和再入院风险。

结论

重度TR显著恶化心源性休克患者的生存,尤其是那些患有晚期CKD的患者,由右心室功能障碍介导。CKD严重程度评估可能会增强瓣膜干预的患者分层。需要进行随机研究以进一步验证这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a076/12175724/4e49b4b7e4c5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a076/12175724/4e49b4b7e4c5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a076/12175724/4e49b4b7e4c5/gr2.jpg

相似文献

1
Tricuspid regurgitation and chronic kidney disease in patients with cardiogenic shock: Review of the literature and real-world experience from a single center.心源性休克患者的三尖瓣反流与慢性肾脏病:文献综述及单中心真实世界经验
Int J Cardiol Heart Vasc. 2025 Jun 7;59:101716. doi: 10.1016/j.ijcha.2025.101716. eCollection 2025 Aug.
2
Early readmissions after percutaneous mechanical circulatory support-assisted percutaneous coronary intervention: Insights from the nationwide readmissions database.经皮机械循环支持辅助经皮冠状动脉介入治疗后的早期再入院:来自全国再入院数据库的见解
Cardiovasc Revasc Med. 2025 Jun 13. doi: 10.1016/j.carrev.2025.06.002.
3
Real-World Clinical Outcomes and Health Care Utilization in Patients With Severe Tricuspid Regurgitation.重度三尖瓣反流患者的真实世界临床结局与医疗保健利用情况
Struct Heart. 2025 Mar 27;9(5):100463. doi: 10.1016/j.shj.2025.100463. eCollection 2025 May.
4
Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study.门诊开始使用环硅酸锆钠治疗后肾素-血管紧张素-醛固酮系统抑制剂的剂量:GALVANIZE RAASi真实世界证据研究
Adv Ther. 2025 Jun 18. doi: 10.1007/s12325-025-03254-z.
5
Influence of Hospital Ownership on Patient Outcomes in ST-Elevation Myocardial Infarction-Induced Cardiogenic Shock Undergoing Revascularization: A Retrospective Cohort Study.医院所有权对接受血运重建的ST段抬高型心肌梗死所致心源性休克患者预后的影响:一项回顾性队列研究
Cureus. 2025 May 20;17(5):e84471. doi: 10.7759/cureus.84471. eCollection 2025 May.
6
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.
7
Isolated Limb Perfusion Can Avert Amputation Indication in Initially Nonsalvageable Sarcomas of the Extremities.孤立肢体灌注可避免最初无法挽救的四肢肉瘤的截肢指征。
Clin Orthop Relat Res. 2025 Jun 19. doi: 10.1097/CORR.0000000000003584.
8
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
9
Prevalence and Management of Multiple Valvular Heart Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Multicenter Study on the Impact of Staged Valvular Interventions on Outcomes.经导管主动脉瓣置换术患者中多瓣膜心脏病的患病率及管理:关于分期瓣膜干预对结局影响的多中心研究
J Am Heart Assoc. 2025 Jun 17;14(12):e040150. doi: 10.1161/JAHA.124.040150. Epub 2025 Jun 5.
10
Biventricular remodeling after cone repair in Ebstein anomaly: magnetic resonance imaging data analysis.埃布斯坦畸形圆锥修复术后双心室重塑:磁共振成像数据分析
J Thorac Dis. 2025 May 30;17(5):2980-2988. doi: 10.21037/jtd-2024-2185. Epub 2025 May 28.

本文引用的文献

1
SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health.钠-葡萄糖协同转运蛋白2抑制剂在慢性肾脏病中的应用:支持心血管、肾脏及代谢健康
Kidney Med. 2024 Jun 8;6(8):100851. doi: 10.1016/j.xkme.2024.100851. eCollection 2024 Aug.
2
Transcatheter Valve Replacement in Severe Tricuspid Regurgitation.严重三尖瓣反流的经导管瓣膜置换术
N Engl J Med. 2025 Jan 9;392(2):115-126. doi: 10.1056/NEJMoa2401918. Epub 2024 Oct 30.
3
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock: A Substudy of the DanGer Shock Randomized Clinical Trial.
微轴流泵在梗死相关心源性休克中的血流动力学和代谢效应:DanGer休克随机临床试验的一项子研究
JAMA Cardiol. 2025 Jan 1;10(1):9-16. doi: 10.1001/jamacardio.2024.4197.
4
TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention.三尖瓣评分:用于预测行经导管三尖瓣介入治疗患者死亡率/住院率的风险评分。
JACC Cardiovasc Interv. 2024 Sep 23;17(18):2170-2179. doi: 10.1016/j.jcin.2024.08.009.
5
Cardiovascular Complications With Delivery Hospitalizations in Patients With Pulmonary Hypertension: A Nationwide Study From 2011 to 2020.肺动脉高压患者分娩住院的心血管并发症:2011 年至 2020 年的全国性研究。
J Am Heart Assoc. 2024 Jun 4;13(11):e031632. doi: 10.1161/JAHA.123.031632. Epub 2024 May 28.
6
Effects of SGLT2 inhibitors on right ventricular function in heart failure patients: Updated meta-analysis of the current literature.钠-葡萄糖协同转运蛋白 2 抑制剂对心力衰竭患者右心室功能的影响:当前文献的更新荟萃分析。
Kardiol Pol. 2024;82(4):416-422. doi: 10.33963/v.phj.100199. Epub 2024 Apr 19.
7
Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.微轴流泵与常规治疗在梗死相关性心源性休克中的比较。
N Engl J Med. 2024 Apr 18;390(15):1382-1393. doi: 10.1056/NEJMoa2312572. Epub 2024 Apr 7.
8
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction.心原性休克与急性失代偿性心力衰竭和急性心肌梗死的区别。
ESC Heart Fail. 2023 Dec;10(6):3472-3482. doi: 10.1002/ehf2.14510. Epub 2023 Sep 18.
9
1-Year Outcomes of Transcatheter Tricuspid Valve Repair.经导管三尖瓣修复术的 1 年结果。
J Am Coll Cardiol. 2023 May 9;81(18):1766-1776. doi: 10.1016/j.jacc.2023.02.049.
10
Right Ventricular Failure.右心室衰竭
N Engl J Med. 2023 Mar 23;388(12):1111-1125. doi: 10.1056/NEJMra2207410.